Lion Corporation makes household and personal care staples in Japan, including Lion-branded oral care such as Clinica toothpaste, laundry and dishwashing detergents, and hygiene products, selling through drugstores, supermarkets and e-commerce. Its edge is brand strength and distribution in a category where consumers rarely switch, which supports a 46.7% gross margin and a 12.3% operating margin. Revenue growth of 11.8% is well ahead of what a defensive staples business usually delivers, so the question for a PM is how much of that is durable pricing and volume versus one-off or inflation-driven gains. The stock trades at 17.7 times trailing earnings but 26.5 times forward, a gap that implies the market expects earnings to fall or plateau, so the forward multiple is worth testing against management's guidance before anything else. With a 9.7% return on equity and no index membership, the name sits outside the usual screens, which may be why it merits a closer look.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 01:52 CEST | ACCE price target | ¥2000 | first publication | ¥1831 |
Answered from Lion Corporation fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| 4912.T Lion Corporation | ¥1844.00 | - | - | 17.7x | 9.7% | 67 | 70 |
| ITP.PA Interparfums SA | €34.50 | €24 | 45% above | 25.8x | 17.1% | 83 | 59 |
| 4967.T Kobayashi Pharmaceutical Co., Ltd. | ¥7150.00 | - | - | 327.1x | 0.8% | 46 | 47 |
| IPAR Interparfums Inc. Common Stock | $116.07 | $96 | 21% above | 22.0x | 19.1% | 77 | 62 |
| COTY Coty Inc. Class A Common Stock | $3.21 | $5 | 32% below | - | -16.1% | 38 | 47 |
| 4527.T Rohto Pharmaceutical Co.,Ltd. | ¥2851.50 | - | - | 20.0x | 10.9% | 67 | 66 |
| COLPAL.NS Colgate-Palmolive (India) Limited | ₹1685.00 | - | - | 32.1x | - | 100 | 52 |
Where 4912.T ranks against its sector peers on each metric.